- Must have met the inclusion criteria for the preceding double-blind BID study in
diabetic neuropathy or postherpetic neuralgia.
- Must have received study medication under double-blind conditions.
- Patients cannot participate if they experienced a serious adverse event during the
previous double-blind BID study which was determined to be related to the study